Quantcast
Last updated on April 19, 2014 at 5:20 EDT

Latest Innocoll Inc. Stories

2013-04-17 08:29:11

ASHBURN, Va., April 17, 2013 /PRNewswire/ -- Innocoll, Inc. announced it has entered into an exclusive License and Distribution Agreement with Biomet 3i for its range of CollaCare Dental products. This agreement covers all global territories outside of China and ASEAN, which have been previously partnered. The CollaCare products were developed using Innocoll's proprietary collagen based technologies. The products are comprised of a lyophilized matrix of purified type I collagen available...

2013-02-19 08:32:13

ASHBURN, Va., Feb. 19, 2013 /PRNewswire/ -- Innocoll, Inc. announced the launch of its new CollaCare website, www.collacareproducts.com. The new, standalone website is designed to be the primary source of information on the full range of products in the CollaCare family for patients, practitioners and marketing partners. All key information on the product family has been incorporated onto the website in a readily accessible and user friendly manner. Innocoll's CollaCare portfolio of...

2013-02-06 08:26:35

ASHBURN, Va., Feb. 6, 2013 /PRNewswire/ -- Innocoll, Inc. announced that the following series of three articles presenting Phase 2 clinical data for its bupivacaine-collagen implant, XaraColl(®), have recently been published in the Journal of Pain Research (JPR): Clinical evaluation of XaraColl®, a bupivacaine-collagen implant, for postoperative analgesia in two multicenter, randomized, double-blind, placebo-controlled pilot studies. A randomized, multicenter, pilot study comparing...

2012-04-03 02:26:44

ASHBURN, Va., April 3, 2012 /PRNewswire/ -- Innocoll Inc. announces that its distribution network for CollaGUARD has now been expanded to cover 34 countries including Europe, China, SE Asia, Canada and the Middle East. The Company expects to have partnered CollaGUARD in 75 countries by the end of 2012, including the US and Japan, which are major markets for adhesion barrier products. In addition to recent approvals in the EU and other territories, Innocoll has also submitted filings in...

2012-02-17 06:00:00

ASHBURN, Va., Feb. 17, 2012 /PRNewswire/ -- Innocoll, Inc. announced that it has held an End-of-Phase 2 meeting with the FDA to present the results of the Phase 2 clinical studies completed for XaraColl® and to discuss the proposed safety and efficacy studies to be conducted in Phase 3. XaraColl® is being developed for postoperative analgesia and Innocoll plans to undertake its Phase 3 program in patients undergoing hernia repair. FDA agreed to the Phase 3 clinical studies that...

2012-02-01 06:00:00

ASHBURN, Va., Feb. 1, 2012 /PRNewswire/ -- Innocoll Inc. announced it has entered into a License and Distribution Agreement with Flynn Pharma Ltd. in the United Kingdom and with Inresa Arzneimittel GmbH in Germany for CollaGUARD surgical adhesion barrier for the prevention of postoperative adhesions following abdominal and pelvic surgery. Dr. Michael Myers, President and CEO stated, "We are pleased to announce these partnerships for two of the key markets in the EU and we look forward to a...

2011-11-15 06:16:00

ASHBURN, Va., Nov. 15, 2011 /PRNewswire/ -- Innocoll Inc. announced it has entered into a License and Distribution Agreement with Merus Labs Inc. in Canada for CollaGUARD surgical adhesion barrier for the prevention of postoperative adhesions following abdominal and pelvic surgery. Dr. Michael Myers, President and CEO stated, "We are pleased to announce the expansion of our partnership with Merus to include CollaGUARD and we look forward to the successful launch of the product in...

2011-10-19 06:00:00

ASHBURN, Va. ,Oct. 19, 2011 /PRNewswire/ -- Innocoll, Inc. announced it has entered into a License and Distribution Agreement with Pioneer Pharma in China for CollaGUARD surgical adhesion barrier for the prevention of postoperative adhesions following abdominal and pelvic surgery. Dr. Michael Myers, President and CEO stated "This is an exciting development for Innocoll. China is becoming an increasingly important and dynamic market for medical products and we are very pleased to have...

2011-10-11 06:00:00

ASHBURN, Va., Oct. 11, 2011 /PRNewswire/ -- Innocoll, Inc. announces the approval of CollaGUARD surgical adhesion barrier for the prevention of postoperative adhesions following abdominal and pelvic surgery. The product will be launched this year through a network of distribution partnerships. The company also plans to seek approval in a number of additional territories, including Australia, Canada, the MENA region, South East Asia, and to initiate the studies required for registration in...

2011-09-19 06:00:00

ASHBURN, Va., Sept. 19, 2011 /PRNewswire/ -- Innocoll, Inc. announced the following update for its range of advanced wound care and related collagen-based products. Based on a series of recent regulatory approvals and product listings, Innocoll has added six more products in a variety of sponge, film, bilayer, powder, gel and spray formats that are available for commercialization in the US, EU and other markets such as Canada and New Zealand. These products include:...